138 related articles for article (PubMed ID: 27074627)
1. Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity.
Novakova Z; Wozniak K; Jancarik A; Rais R; Wu Y; Pavlicek J; Ferraris D; Havlinova B; Ptacek J; Vavra J; Hin N; Rojas C; Majer P; Slusher BS; Tsukamoto T; Barinka C
J Med Chem; 2016 May; 59(10):4539-50. PubMed ID: 27074627
[TBL] [Abstract][Full Text] [Related]
2. Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities.
Novakova Z; Cerny J; Choy CJ; Nedrow JR; Choi JK; Lubkowski J; Berkman CE; Barinka C
FEBS J; 2016 Jan; 283(1):130-43. PubMed ID: 26460595
[TBL] [Abstract][Full Text] [Related]
3. Carborane-containing urea-based inhibitors of glutamate carboxypeptidase II: Synthesis and structural characterization.
Youn S; Kim KI; Ptacek J; Ok K; Novakova Z; Kim Y; Koo J; Barinka C; Byun Y
Bioorg Med Chem Lett; 2015 Nov; 25(22):5232-6. PubMed ID: 26459214
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II.
Stoermer D; Liu Q; Hall MR; Flanary JM; Thomas AG; Rojas C; Slusher BS; Tsukamoto T
Bioorg Med Chem Lett; 2003 Jul; 13(13):2097-100. PubMed ID: 12798312
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.
Barinka C; Hlouchova K; Rovenska M; Majer P; Dauter M; Hin N; Ko YS; Tsukamoto T; Slusher BS; Konvalinka J; Lubkowski J
J Mol Biol; 2008 Mar; 376(5):1438-50. PubMed ID: 18234225
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of P1'-diversified urea-based inhibitors of glutamate carboxypeptidase II.
Pavlicek J; Ptacek J; Cerny J; Byun Y; Skultetyova L; Pomper MG; Lubkowski J; Barinka C
Bioorg Med Chem Lett; 2014 May; 24(10):2340-5. PubMed ID: 24731280
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors.
Ferraris DV; Shukla K; Tsukamoto T
Curr Med Chem; 2012; 19(9):1282-94. PubMed ID: 22304717
[TBL] [Abstract][Full Text] [Related]
8. Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesis.
Mlcochová P; Plechanovová A; Barinka C; Mahadevan D; Saldanha JW; Rulísek L; Konvalinka J
FEBS J; 2007 Sep; 274(18):4731-41. PubMed ID: 17714508
[TBL] [Abstract][Full Text] [Related]
9. Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA.
Mesters JR; Henning K; Hilgenfeld R
Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):508-13. PubMed ID: 17372356
[TBL] [Abstract][Full Text] [Related]
10. Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II.
Tykvart J; Schimer J; Jančařík A; Bařinková J; Navrátil V; Starková J; Šrámková K; Konvalinka J; Majer P; Šácha P
J Med Chem; 2015 May; 58(10):4357-63. PubMed ID: 25923815
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain.
Rais R; Vávra J; Tichý T; Dash RP; Gadiano AJ; Tenora L; Monincová L; Bařinka C; Alt J; Zimmermann SC; Slusher CE; Wu Y; Wozniak K; Majer P; Tsukamoto T; Slusher BS
J Med Chem; 2017 Sep; 60(18):7799-7809. PubMed ID: 28759215
[TBL] [Abstract][Full Text] [Related]
12. Glutamate carboxypeptidase II: an overview of structural studies and their importance for structure-based drug design and deciphering the reaction mechanism of the enzyme.
Pavlícek J; Ptácek J; Barinka C
Curr Med Chem; 2012; 19(9):1300-9. PubMed ID: 22304708
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.
Bailey S; Bolognese B; Faller A; Louis-Flamberg P; MacPherson DT; Mayer RJ; Marshall LA; Milner PH; Mistry J; Smith DG; Ward JG
Bioorg Med Chem Lett; 1999 Nov; 9(21):3165-70. PubMed ID: 10560745
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.
Kozikowski AP; Zhang J; Nan F; Petukhov PA; Grajkowska E; Wroblewski JT; Yamamoto T; Bzdega T; Wroblewska B; Neale JH
J Med Chem; 2004 Mar; 47(7):1729-38. PubMed ID: 15027864
[TBL] [Abstract][Full Text] [Related]
15. Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity.
Plechanovová A; Byun Y; Alquicer G; Skultétyová L; Mlčochová P; Němcová A; Kim HJ; Navrátil M; Mease R; Lubkowski J; Pomper M; Konvalinka J; Rulíšek L; Bařinka C
J Med Chem; 2011 Nov; 54(21):7535-46. PubMed ID: 21923190
[TBL] [Abstract][Full Text] [Related]
16. Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization.
Barinka C; Byun Y; Dusich CL; Banerjee SR; Chen Y; Castanares M; Kozikowski AP; Mease RC; Pomper MG; Lubkowski J
J Med Chem; 2008 Dec; 51(24):7737-43. PubMed ID: 19053759
[TBL] [Abstract][Full Text] [Related]
17. Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II.
Barinka C; Rovenská M; Mlcochová P; Hlouchová K; Plechanovová A; Majer P; Tsukamoto T; Slusher BS; Konvalinka J; Lubkowski J
J Med Chem; 2007 Jul; 50(14):3267-73. PubMed ID: 17567119
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.
Huang A; Joseph-McCarthy D; Lovering F; Sun L; Wang W; Xu W; Zhu Y; Cui J; Zhang Y; Levin JI
Bioorg Med Chem; 2007 Sep; 15(18):6170-81. PubMed ID: 17606376
[TBL] [Abstract][Full Text] [Related]
19. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W
Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183
[TBL] [Abstract][Full Text] [Related]
20. S1 pocket of glutamate carboxypeptidase II: a new binding site for amyloid-β degradation.
Lee SK; Kim H; Cheong YH; Kim MJ; Jo SA; Youn HS; Park SI
Biochem Biophys Res Commun; 2013 Sep; 438(4):765-71. PubMed ID: 23891752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]